Serum predominantly activates MAPK and Akt kinases in EGFR- and ErbB2- over-expressing cells, respectively [1]

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 295-297

  Tari, Ana Maria ^a,b   Lopez Berestein, Gabriel ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

CELL TRANSFORMATION; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LETTER; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

BLOOD; BREAST NEOPLASMS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0034029237     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<295::AID-IJC22>3.0.CO;2-K     Document Type: Letter

References (16)